The spectrum of subjective effects of antipsychotic medication

Acta Neuropsychiatrica

Volumn 15, Issue 5, 2003, Pages 274-279

  Wolters, Hugo A ^a   Knegtering, Rikus ^b   Wiersma, Durk ^b   Van den Bosch, Robert J ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NONE

Author keywords

Antipsychotics; Schizophrenia; Side effects; Subjective

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ADULT; ANTICHOLINERGIC EFFECT; ANXIETY; APPETITE; ARTICLE; ATTENTION; COGNITION; CREATIVITY; DEPRESSION; DROWSINESS; EMOTION; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; FEMALE; HUMAN; INTERVIEW; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MEMORY; QUESTIONNAIRE; RESTLESSNESS; SELF CONTROL; SIDE EFFECT; SOCIAL INTERACTION; WEIGHT GAIN;

EID: 0142106991     PISSN: 09242708     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1601-5215.2003.00038.x     Document Type: Article

References (17)

1. VAN PUTTEN T, MAY PR, MARDER SR, WITTMANN LA. Subjective response to antipsychotic drugs. Arch General Psychiatry 1981;38:187-190.
2. WEIDEN PJ, MANN JJ, DIXON L, HAAS G, DECHILLO N, FRANCES AJ. Is neuroleptic dysphoria a healthy response? Compr Psychiatry 1989;30:546-552.
3. NABER D, WALTHER A, KIRCHER T, HAYEK D, HOLZBACH R. Subjective effects of neuroleptics predict compliance. In: GAEBEL W AWAD AG, eds. Predictions of Neuroleptic Treatment Outcome in Schizophrenia. Wien: Springer Verlag, 1994:85-98.
4. AGARWAL MR, SHARMA VK, KISHORE-KUMAR KV, LOWE D. Non-compliance with treatment in patients suffering from schizophrenia: a study to evaluate possible contributing factors. Int J Soc Psychiatry 1998;44:92-106.
5. CABEZA GI, AMADOR SM, LOPEZ AC, DE CHAVEZ CM. Subjective response to antipsychotics in schizophrenic patients: clinical implications and related factors. Schizophr Res 2000;41:349-355.
6. VAN PUTTEN T, MAY PR. Subjective response as a predictor of outcome in pharmacotherapy: the consumer has a point. Arch General Psychiatry 1978;35:477-480.
7. HOGAN TP, AWAD AG, EASTWOOD MR. Early subjective response and prediction of outcome to neuroleptic drug therapy in schizophrenia. Can J Psychiatry 1985;30:246-248.
8. HOGAN TP, AWAD AG. Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures. Psychol Med 1992;22:347-352.
9. NABER D. Subjective experiences of schizophrenic patients treated with antipsychotic medication. Int Clin Psychopharmacol 1998;13:S41-S45.
10. VAN PUTTEN T. Why do schizophrenic patients refuse to take their drugs? Arch General Psychiatry 1974;31:67-72.
11. AWAD AG, HOGAN TP, VORUGANTI LN P, HESLEGRAVE RJ. Patients' subjective experiences on antipsychotic medications: implications for outcome and quality of life. Int Clin Psychopharmacol 1995;10(Suppl. 3):123-132.
12. AWAD AG. Subjective response to neuroleptics in schizophrenia. Schizophr Bull 1993;19:609-618.
13. NABER D. A self-rating scale to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. Int Clin Psychopharmacol 1995;10(Suppl. 3):133-138.
14. NABER D, MORITZ S, LAMBERT M et al. Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic medication. Schizophr Res 2001;50:79-88.
15. DIAMOND R. Drugs and the Quality of Life: The Patient's Point of View. J Clin Psychiatry 1985;46:29-35.
16. LINGJAERDE O, AHLFORS UG, BECH P, DENCKER S, ELGEN K. The UKU side effect scale: a new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand 1987;34(Suppl. 76):1-100.
17. HOGAN TP, AWAD AG, EASTWOOD MR. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 1983;13:77-183.